Ana Lucrecia Woodward

Array ( [id] => 5875347 [patent_doc_number] => 20060167014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Piperazine compounds and medicinal use thereof' [patent_app_type] => utility [patent_app_number] => 11/298980 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68140 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167014.pdf [firstpage_image] =>[orig_patent_app_number] => 11298980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899863 [patent_doc_number] => 20080119477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'N-Biaryl and N-Arylheteroaryl Piperazine Derivatives as Modulators of the 5Ht2c Receptor Useful For the Treatment of Disorders Related Thereto' [patent_app_type] => utility [patent_app_number] => 11/792894 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22087 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119477.pdf [firstpage_image] =>[orig_patent_app_number] => 11792894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664230 [patent_doc_number] => 20080255137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'N-Biaryl and N-Arylheteroaryl 2-Substituted Piperazine Derivatives as Modulators of the 5ht2c Receptor Useful for the Treatment of Disorders Related Thereto' [patent_app_type] => utility [patent_app_number] => 11/792742 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21388 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255137.pdf [firstpage_image] =>[orig_patent_app_number] => 11792742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814981 [patent_doc_number] => 20060084662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Phenyl-piperazine derivatives as serotonin reuptake inhibitors' [patent_app_type] => utility [patent_app_number] => 11/296835 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7754 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084662.pdf [firstpage_image] =>[orig_patent_app_number] => 11296835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7729786 [patent_doc_number] => 08101619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition' [patent_app_type] => utility [patent_app_number] => 11/294603 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8539 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101619.pdf [firstpage_image] =>[orig_patent_app_number] => 11294603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743643 [patent_doc_number] => 20060089368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Phenyl-piperazine derivatives as serotonin reuptake inhibitors' [patent_app_type] => utility [patent_app_number] => 11/296836 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7752 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089368.pdf [firstpage_image] =>[orig_patent_app_number] => 11296836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844445 [patent_doc_number] => 20060122177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites' [patent_app_type] => utility [patent_app_number] => 11/294611 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3494 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122177.pdf [firstpage_image] =>[orig_patent_app_number] => 11294611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844438 [patent_doc_number] => 20060122175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Benzdioxane piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites' [patent_app_type] => utility [patent_app_number] => 11/294610 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6866 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122175.pdf [firstpage_image] =>[orig_patent_app_number] => 11294610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814863 [patent_doc_number] => 20060084641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'IL-8 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/294013 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14028 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084641.pdf [firstpage_image] =>[orig_patent_app_number] => 11294013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814977 [patent_doc_number] => 20060084661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'IL-8 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/294660 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10655 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084661.pdf [firstpage_image] =>[orig_patent_app_number] => 11294660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 460072 [patent_doc_number] => 07241761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-10 [patent_title] => 'Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups' [patent_app_type] => utility [patent_app_number] => 11/291216 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9721 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/241/07241761.pdf [firstpage_image] =>[orig_patent_app_number] => 11291216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311111 [patent_doc_number] => 07528135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'Pyridine derivatives as H3 antagonists' [patent_app_type] => utility [patent_app_number] => 11/290675 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15409 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528135.pdf [firstpage_image] =>[orig_patent_app_number] => 11290675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676911 [patent_doc_number] => 20080214542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands' [patent_app_type] => utility [patent_app_number] => 11/720526 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18405 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214542.pdf [firstpage_image] =>[orig_patent_app_number] => 11720526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876464 [patent_doc_number] => 07358251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'N-sulfonylurea apoptosis promoters' [patent_app_type] => utility [patent_app_number] => 11/288997 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14907 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358251.pdf [firstpage_image] =>[orig_patent_app_number] => 11288997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960633 [patent_doc_number] => 20080275058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'N-Substituted-1H-Quinoline-2,4-Diones, Preparation Method Thereof, And Pharmaceutical Composition Containing The Same' [patent_app_type] => utility [patent_app_number] => 12/065565 [patent_app_country] => US [patent_app_date] => 2005-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29200 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275058.pdf [firstpage_image] =>[orig_patent_app_number] => 12065565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5096202 [patent_doc_number] => 20070117811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazinealkylamide derivatives, and therapeutic use thereof as 5-HT7 receptor ligands' [patent_app_type] => utility [patent_app_number] => 11/283608 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9703 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20070117811.pdf [firstpage_image] =>[orig_patent_app_number] => 11283608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5716135 [patent_doc_number] => 20060079498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 11/282057 [patent_app_country] => US [patent_app_date] => 2005-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18567 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079498.pdf [firstpage_image] =>[orig_patent_app_number] => 11282057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422992 [patent_doc_number] => 20090149447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Novel M3 Muscarinic Acetylcholine Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 11/719336 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22238 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149447.pdf [firstpage_image] =>[orig_patent_app_number] => 11719336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199773 [patent_doc_number] => 20070299091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Azaindole Carboxamides' [patent_app_type] => utility [patent_app_number] => 11/667601 [patent_app_country] => US [patent_app_date] => 2005-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17013 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299091.pdf [firstpage_image] =>[orig_patent_app_number] => 11667601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 680134 [patent_doc_number] => 07084141 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Inhibitors of macrophase migration inhibitory factor and methods for identifying the same' [patent_app_type] => utility [patent_app_number] => 11/268375 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 42615 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/084/07084141.pdf [firstpage_image] =>[orig_patent_app_number] => 11268375 [rel_patent_id] =>[rel_patent_doc_number] =>)